RFG Advisory’s Celgene Corp CELG Stock Holding History

RFG Advisory’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-2,463	Closed	-$220K	–	328
2018 Q3	$220K	Buy	+2,463	New	+$218K	0.06%	269
2017 Q4	–	Sell	-1,620	Closed	-$227K	–	182
2017 Q3	$227K	Buy	+1,620	New	+$221K	0.14%	146
2016 Q3	–	Sell	-6,010	Closed	-$593K	–	99
2016 Q2	$593K	Buy	6,010 +455	+8%	+$47.1K	0.52%	35
2016 Q1	$556K	Buy	+5,555	New	+$572K	0.43%	34

Other funds holding CELG

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

RFG Advisory's CELG Position: Q4 2018 in Review

RFG Advisory sold out of Celgene Corp (CELG) in Q4 2018, closing a stake of 2,463 shares — an estimated $220K sold.

RFG Advisory first reported a position in CELG in Q1 2016 and held it in 4 quarters. The position peaked at $593K in Q2 2016. 1,317 funds tracked by Wall St. Rank hold CELG as of Q4 2018.

RFG Advisory reported no remaining Celgene Corp position as of Q4 2018 after selling out during the quarter.
RFG Advisory sold 2,463 Celgene Corp shares in Q4 2018, an estimated $220K.
RFG Advisory first reported a position in Celgene Corp in Q1 2016 and held it in 4 quarters.
RFG Advisory's Celgene Corp position peaked at $593K in Q2 2016.
1,317 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2018.

Based on RFG Advisory's 13F filing for Q4 2018, filed 15 Feb 2019.